MICHAEL G. GREY - 04 Oct 2024 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OKUR	Stock Option (right to buy)	Award	$0	+15,300		$0.000000	15,300	04 Oct 2024	Class A Common Stock	15,300	$18.20	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	1/36th of the shares subject to the option shall vest on November 4, 2024 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.